BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7529327)

  • 1. Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy.
    Langlais PJ; Zhang SX; Weilersbacher G; Hough LB; Barke KE
    J Neurosci Res; 1994 Aug; 38(5):565-74. PubMed ID: 7529327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of brain histamine produces regionally selective protection against thiamine deficiency-induced lesions in the rat.
    Langlais PJ; McRee RC; Nalwalk JA; Hough LB
    Metab Brain Dis; 2002 Sep; 17(3):199-210. PubMed ID: 12322789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy.
    Todd KG; Butterworth RF
    Exp Neurol; 1998 Jan; 149(1):130-8. PubMed ID: 9454622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy.
    Hazell AS; Wang C
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):200-7. PubMed ID: 15573404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased histamine release and granulocytes within the thalamus of a rat model of Wernicke's encephalopathy.
    McRee RC; Terry-Ferguson M; Langlais PJ; Chen Y; Nalwalk JW; Blumenstock FA; Hough LB
    Brain Res; 2000 Mar; 858(2):227-36. PubMed ID: 10708674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801.
    Langlais PJ; Zhang SX
    J Neurochem; 1993 Dec; 61(6):2175-82. PubMed ID: 8245970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions.
    Zhang SX; Weilersbacher GS; Henderson SW; Corso T; Olney JW; Langlais PJ
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):255-67. PubMed ID: 7876893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.
    Langlais PJ
    Metab Brain Dis; 1995 Mar; 10(1):31-44. PubMed ID: 7596327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical and subcortical white matter damage without Wernicke's encephalopathy after recovery from thiamine deficiency in the rat.
    Langlais PJ; Zhang SX
    Alcohol Clin Exp Res; 1997 May; 21(3):434-43. PubMed ID: 9161603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in rats.
    Robinson JK; Mair RG
    Behav Neurosci; 1992 Aug; 106(4):623-33. PubMed ID: 1386989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of aversively conditioned learning and memory in rats recovered from pyrithiamine-induced thiamine deficiency.
    Mair RG; Otto TA; Knoth RL; Rabchenuk SA; Langlais PJ
    Behav Neurosci; 1991 Jun; 105(3):351-9. PubMed ID: 1907456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo microdialysis in an animal model of neurological disease: thiamine deficiency (Wernicke) encephalopathy.
    Todd KG; Butterworth RF
    Methods; 2001 Jan; 23(1):55-61. PubMed ID: 11162149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain.
    Langlais PJ; Mair RG
    J Neurosci; 1990 May; 10(5):1664-74. PubMed ID: 1970604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebral free radical production during thiamine deficiency.
    Langlais PJ; Anderson G; Guo SX; Bondy SC
    Metab Brain Dis; 1997 Jun; 12(2):137-43. PubMed ID: 9203158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late N-methyl-D-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy.
    Ayala GX; Tapia R
    Eur J Neurosci; 2005 Dec; 22(12):3067-76. PubMed ID: 16367773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study.
    Pfefferbaum A; Adalsteinsson E; Bell RL; Sullivan EV
    Neuropsychopharmacology; 2007 May; 32(5):1159-77. PubMed ID: 16723995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy.
    Hazell AS; Rao KV; Danbolt NC; Pow DV; Butterworth RF
    J Neurochem; 2001 Aug; 78(3):560-8. PubMed ID: 11483659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response latency and accuracy on a pretrained nonmatching-to-sample task in rats recovered from pyrithiamine-induced thiamine deficiency.
    Knoth RL; Mair RG
    Behav Neurosci; 1991 Jun; 105(3):375-85. PubMed ID: 1907458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes.
    Hazell AS; Pannunzio P; Rama Rao KV; Pow DV; Rambaldi A
    Glia; 2003 Aug; 43(2):175-84. PubMed ID: 12838509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.